Magdalena Bujalska-Zadrozny

Dr. Magdalena Bujalska-Zadrozny


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AGAgata Gurba
Agata Gurba
PTPrzemysław Taciak
Przemysław Taciak
MSMariusz Sacharczuk
Mariusz Sacharczuk
IMIzabela Mlynarczuk-Bialy
Izabela Mlynarczuk-Bialy
MBMagdalena Bujalska-Zadrozny
Magdalena Bujalska-Zadrozny
JFJakub Fichna
Jakub Fichna
Cancer is one of the leading causes of morbidity and mortality worldwide. Colorectal cancer (CRC) is the third most frequently diagnosed cancer in men and the second in women. Standard patterns of antitumor therapy, including cisplatin, are ineffective due to their lack of specificity for tumor cells, development of drug resistance, and severe side effects. For this reason, new methods and strategies for CRC treatment are urgently needed. Current research includes novel platinum (Pt)- and other metal-based drugs such as gold (Au), silver (Ag), iridium (Ir), or ruthenium (Ru). Au(III) compounds are promising drug candidates for CRC treatment due to their structural similarity to Pt(II). Their advantage is their relatively good solubility in water, but their disadvantage is an unsatisfactory stability under physiological conditions. Due to these limitations, work is still underway to improve the formula of Au(III) complexes by combining with various types of ligands capable of stabilizing the Au(III) cation and preventing its reduction under physiological conditions. This review summarizes the achievements in the field of stable Au(III) complexes with potential cytotoxic activity restricted to cancer cells. Moreover, it has been shown that not nucleic acids but various protein structures such as thioredoxin reductase (TrxR) mediate the antitumor effects of Au derivatives. The state of the art of the in vivo studies so far conducted is also described.

1 March 2017 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
MBMagdalena Bujalska-Zadrozny
Magdalena Bujalska-Zadrozny
JTJan Tatarkiewicz
Jan Tatarkiewicz
KKKamila Kulik
Kamila Kulik
MFMałgorzata Filip
Małgorzata Filip
MNMarek Naruszewicz
Marek Naruszewicz

7 November 2007 in Pharmacology
Verified
Journal Article
Closed access
MBMagdalena Bujalska-Zadrozny
Magdalena Bujalska-Zadrozny
JTJan Tatarkiewicz
Jan Tatarkiewicz
ACAnna de Cordé
Anna de Cordé
SGStanisław Witold Gumułka
Stanisław Witold Gumułka
We examined a possible involvement of cyclooxygenase (COX) and nitric oxide synthase (NOS) products in hyperalgesia occurring during streptozotocin (STZ)-induced diabetes. Indomethacin and celecoxib were used as relatively selective inhibitors of COX-1 and COX-2, respectively. NOS inhibitors included: non-specific inhibitor NG-nitro-L-arginine and L-N6-(1-iminoethyl)lysine preferentially acting on inducible NOS (iNOS) as well as 7-nitroindazole relatively specific inhibitor neuronal NOS (nNOS). The above-mentioned agents, except 7-nitroindazole, suppressed hyperalgesia occurring after administration of STZ. The results of the study suggest participation of COX-1, COX-2 and iNOS, but not nNOS, in transmission of pain stimuli in STZ-induced diabetic hyperalgesia.

17 April 2023 in Toxics
Verified
Journal Article
Open access
PDF file
Michal OrdakMichal Ordak
Michal Ordak
AGAleksandra Gałązka
Aleksandra Gałązka
TNTadeusz Nasierowski
Tadeusz Nasierowski
EMElzbieta Muszynska
Elzbieta Muszynska
MBMagdalena Bujalska-Zadrozny
Magdalena Bujalska-Zadrozny
In recent months, there has been a new trend involving the consumption of Amanita muscaria. The aim of this article was to investigate the reasons for consumption, the form taken and the adverse symptoms that were indicated by those consuming Amanita muscaria. After analysing 5600 comments, 684 people were included in the study, who, in social media groups such as Facebook, stated the purpose of consuming the mushroom (n = 250), the form of mushroom they were taking (n = 198) or the adverse symptoms they experienced (n = 236). The gender of the subjects differentiated the parameters analysed. In the study group of women, the main purpose of consuming Amanita muscaria was to reduce pain, as well as to reduce skin problems, while in men it was mainly to relieve stress, reduce the severity of depressive symptoms and reduce insomnia (p < 0.001). With regard to the form of mushroom ingested, tincture was predominant in the women’s study group, while dried was predominant in the men (p < 0.001). In terms of side effects, women reported primarily headaches, while men reported nausea, vomiting, abdominal pain and drowsiness (p < 0.001). Advanced research on Amanita muscaria should be carried out to make the community aware of the toxicity of this fungus.

14 August 2008 in Pharmacology
Verified
Journal Article
Closed access
PDF file
MBMagdalena Bujalska-Zadrozny
Magdalena Bujalska-Zadrozny
EMEwelina Malinowska
Ewelina Malinowska
HMHelena Makulska-Nowak
Helena Makulska-Nowak
SGStanisław Witold Gumułka
Stanisław Witold Gumułka
Streptozotocin-induced hyperglycemia accompanied by a chronic decrease in the nociceptive threshold is considered a useful model of experimental hyperalgesia. We examined (1) the effect of the opioid receptor agonists and (2) the effect of the magnesium ions (Mg2+) on the antinociceptive action of opioid agonists in a diabetic neuropathic pain model. When administered alone, opioid agonists like morphine (5 mg/kg i.p.) and fentanyl (0.0625 mg/kg i.p.), as well as the partial agonist buprenorphine (0.075 mg/kg) had only little effect on streptozotocin-induced hyperalgesia. However, pretreatment with Mg2+ at a dose of 40 mg magnesium sulfate/kg i.p. markedly enhanced the analgesic activity of all three investigated opioids. Practical aspects of co-administration of magnesium and opioids in diabetic neuropathy are discussed.

1 November 2009 in Pharmacological Reports
Verified
Journal Article
Closed access
MBMagdalena Bujalska-Zadrozny
Magdalena Bujalska-Zadrozny
HMHelena Makulska-Nowak.
Helena Makulska-Nowak.
SGStanisław W. Gumułka
Stanisław W. Gumułka